Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroMed is a leading medical technology company specializing in the design and manufacture of advanced neurophysiology diagnostic systems. The company's product portfolio includes high-performance solutions for Electroencephalography (EEG), Electromyography (EMG), Evoked Potentials (EP), and Polysomnography (PSG), as well as Intraoperative Monitoring (IOM). Known for its modular and integrated software platforms, MicroMed serves clinical and research institutions globally, providing critical tools for the diagnosis and monitoring of epilepsy, sleep disorders, and neuromuscular conditions. In early 2023, the company was acquired by Natus Medical, further strengthening its position in the global neurodiagnostics market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Micro Med.